Skip to content
★ Sign in to follow
MEDIKALOKA HERMINA Tbk, PT logo

MEDIKALOKA HERMINA Tbk, PT Stock: price and insider trades · Indonesia

ID·Mcap IDR 7.6THealth Care

3 insiders bought €432k of shares over the last 90 days, the latest by YULISAR KHIAT, filed 02 Nov 2026.

MEDIKALOKA HERMINA Tbk, PT: what insiders have been doing

Headquartered in Indonesia, MEDIKALOKA HERMINA Tbk, PT belongs to the Health Care sector. Filings by its managers are published through OJK / IDX. In the past year (3 November 2025 to 3 November 2026), 22 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 22 purchases totalling €737k, made by 3 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €123k, the purchase published on 2 November 2026 by Yulisar Khiat is the largest of the period (0.033% of market cap). The buyers include 2 senior executives and 1 board member.

For context, the typical company on the same exchange (median of 312 companies) published 3 filings over the same period, against 22 filings here. The full history, which starts in 2025, counts 22 purchases against no sales.

In the case of 8 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The clock since the last published purchase (2 November 2026) now reads 6 days. The median gap between a trade and its publication by OJK / IDX is 4 days. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by OJK / IDX and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: Indonesia

Source: Wikidata (CC0).

Insider Decl.
22
Thresholds
n/a
Buy Volume
€737,056
22 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Dr Hasmoro13 buys
Yulisar Khiat6 buys
Yustinus Immanuel Herawan3 buys

Since the insiders bought

  • Filed 15 Sept 2026 · 54 days ago · €10k
    -27.1%
    Entry IDR 680.00 · Close 02 Nov 2026 IDR 496.00
  • Filed 14 Sept 2026 · 55 days ago · €2,490
    -26.5%
    Entry IDR 675.00 · Close 02 Nov 2026 IDR 496.00
  • Filed 10 Sept 2026 · 59 days ago · €53k
    -27.6%
    Entry IDR 685.00 · Close 02 Nov 2026 IDR 496.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate MEDIKALOKA HERMINA Tbk, PT Buy (bullish), based on 14 analysts. Average price target: IDR 1,139.64.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 13,789 of 26,911 companies
50.8
score / 100
Value
51
Quality
50
FCF yld-8.3%
Earn yld5.8%
EV/EBITDA8.3x
ROE6.8%
Gross mgn34%
Net mgn6.0%
Debt/EBITDA2.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

IDR 500.00
Analyst consensus
14 analysts
Buy
IDR 620.00Target IDR 1,139.64(+128%)IDR 1,730.00
Income statement
RevenueIDR 7.1T
Gross profitIDR 2.4T34% margin
EBITDAIDR 1.3T18% margin
Net incomeIDR 429.5B5.1% margin
Valuation
PER (trailing)20.4x
PER (forward)14.4x
P/Book1.4x
Beta-0.19
Balance sheet & cash
Market capIDR 7.6T
Total debtIDR 3.2T
Free Cash Flow-IDR 612.2B
Debt / Equity50%
Profitability & ownership
ROE6.8%
ROA4.7%
% insiders76.2%
% institutions5.2%
Last declaration on 2 November 2026
Declarations22 total
  • ▲
    DireksiExecutives
    321M IDR14IDX
    639,500 shares@ IDR 502.000.0044% mcap4.5% of flowCommon SharesIDXIDX:LK-02112026-0005-1#0
    Canonical exit: 26 Jan 2027 (T+90)
  • ▲
    DireksiExecutives
    2B IDR21IDX
    4,434,300 shares@ IDR 522.000.030% mcap31.4% of flowCommon SharesIDXIDX:LK-02112026-0005-1#1
    Canonical exit: 27 Jan 2027 (T+90)
  • ▲
    DireksiExecutives
    2B IDR21IDX
    4,710,000 shares@ IDR 528.000.033% mcap33.7% of flowCommon SharesIDXIDX:LK-02112026-0005-1#2
    Canonical exit: 28 Jan 2027 (T+90)
  • ▲
    DireksiExecutives
    207M IDR33IDX
    309,500 shares@ IDR 670.000.0026% mcap9.2% of flowCommon SharesIDXIDX:LK-15092026-0007-1#0
    Canonical exit: 10 Dec 2026 (T+90)
  • ▲
    DireksiExecutives
    575M IDR36IDX
    851,300 shares@ IDR 675.000.0075% mcap26.3% of flowCommon SharesIDXIDX:LK-15092026-0007-1#1
    Canonical exit: 13 Dec 2026 (T+90)
  • ▲
    DireksiExecutives
    51M IDR32IDX
    75,000 shares@ IDR 680.000.0006% mcap25.7% of flowCommon SharesIDXIDX:LK-14092026-0007-1#0
    Canonical exit: 7 Dec 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    1B IDR31IDX
    1,542,200 shares@ IDR 685.000.014% mcap14.6% of flowCommon SharesIDXIDX:LK-10092026-0003-1#0
    Canonical exit: 3 Dec 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    45M IDR28IDX
    65,500 shares@ IDR 680.000.0005% mcap0.6% of flowCommon SharesIDXIDX:LK-24082026-0002-1#0
    Canonical exit: 17 Nov 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    235M IDR28IDX
    345,200 shares@ IDR 680.000.0029% mcap3.2% of flowCommon SharesIDXIDX:LK-24082026-0002-1#1
    Canonical exit: 18 Nov 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    219M IDR28IDX
    327,000 shares@ IDR 670.000.0027% mcap3.0% of flowCommon SharesIDXIDX:LK-24082026-0002-1#2
    Canonical exit: 19 Nov 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    998M IDR31IDX
    1,319,000 shares@ IDR 757.000.013% mcap13.3% of flowCommon SharesIDXIDX:LK-18082026-0002-1#0
    Canonical exit: 10 Nov 2026 (T+90)
  • ▲
    DireksiExecutives
    43M IDR34IDX
    60,000 shares@ IDR 710.000.0005% mcap21.9% of flowCommon SharesIDXIDX:LK-14082026-0001-1#0
    Canonical exit: 11 Nov 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    171M IDR28IDX
    218,600 shares@ IDR 780.000.0018% mcap2.4% of flowCommon SharesIDXIDX:LK-12082026-0001-1#0
    Canonical exit: 8 Nov 2026 (T+90)
  • ▲
    DireksiExecutives
    102M IDR37IDX
    130,000 shares@ IDR 785.000.0011% mcap52.4% of flowCommon SharesIDXIDX:LK-10082026-0001-1#0
    Canonical exit: 4 Nov 2026 (T+90)
  • ▲
    DireksiExecutives
    1B IDR35IDX
    1,800,000 shares@ IDR 795.000.015% mcap64.6% of flowCommon SharesIDXIDX:LK-06082026-0004-1#0
    Canonical exit: 3 Nov 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    498M IDR11IDX
    602,500 shares@ IDR 827.000.0054% mcap7.0% of flowCommon SharesIDXIDX:LK-30072026-0005-1#0
    Canonical exit: 21 Oct 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    1B IDR11IDX
    1,419,300 shares@ IDR 775.000.012% mcap14.9% of flowCommon SharesIDXIDX:LK-30072026-0005-1#1
    Canonical exit: 25 Oct 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    30M IDR10IDX
    33,300 shares@ IDR 900.000.0003% mcap0.4% of flowCommon SharesIDXIDX:LK-16072026-0012-1#0
    Canonical exit: 7 Oct 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    348M IDR10IDX
    387,600 shares@ IDR 898.000.0037% mcap4.7% of flowCommon SharesIDXIDX:LK-16072026-0012-1#1
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    1B IDR12IDX
    1,243,500 shares@ IDR 893.000.012% mcap15.4% of flowCommon SharesIDXIDX:LK-16072026-0012-1#2
    Canonical exit: 11 Oct 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    1B IDR9IDX
    1,790,000 shares@ IDR 835.0020.3% of flowCommon SharesIDXIDX:LK-29062026-0007-1#0
    Canonical exit: 22 Sept 2026 (T+90)
  • ▲
    Dewan KomisarisExecutives
    61M IDR7IDX
    43,900 shares@ IDR 1,400.000.9% of flowCommon SharesIDXIDX:LK-09122025-0006-1#0
    Canonical exit: 26 Feb 2026 (T+90)

22 of 22 declarations

About MEDIKALOKA HERMINA Tbk, PT

MEDIKALOKA HERMINA Tbk, PT is a company listed on the XIDX market, specializing in the healthcare sector in Indonesia. It provides medical services and healthcare through its facilities.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations